Khattar Jack A.
SEC CIK 1539937 · EDGAR
BoughtSold
Most active insiders at SUPN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| 2 | Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| 3 | NEWHALL CHARLES W III | Dir | — | $1.27M |
| 4 | Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| 5 | GEMAYEL GEORGES | Dir | — | $1.00M |
| 6 | Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| 7 | Hudson Frederick M. | Dir | — | $271.7K |
| 8 | Sensenig Bethany | Dir | — | $228.3K |
| 9 | Rubin Jonathan | SVP, Chief Medical Off | — | — |
| 10 | Barlow Carrolee | Dir | — | — |
Transactions 104
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 17:12 | 2026-08-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +29.8K | 1.27M | +2% | $0 |
| D | 2026-08-14 17:12 | 2026-08-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $46.57 | -12.6K | 1.26M | -1.0% | -$588.7K |
| 2026-06-22 17:18 | 2026-06-17 | CGTX | COGNITION THERAPEUTICS INC | Khattar Jack A. | Dir | A - Grant | $0.00 | +25.0K | 73.5K | +52% | $0 | |
| MI | 2026-03-16 | 2026-03-13 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale | $50.37 | -35.0K | 969.0K | -3% | -$1.76M |
| I | 2026-03-16 | 2026-03-13 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -12.5K | 993.1K | -1% | — |
| 2026-03-16 | 2026-03-13 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +12.5K | 1.24M | +1% | — | |
| D | 2026-03-10 | 2026-03-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +38.6K | 1.25M | +3% | $0 |
| D | 2026-03-10 | 2026-03-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $54.73 | -16.6K | 1.23M | -1% | -$907.1K |
| D | 2025-10-10 | 2025-10-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +81.2K | 1.27M | +7% | +$2.06M |
| DM | 2025-10-10 | 2025-10-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $50.57 | -59.9K | 1.21M | -5% | -$3.03M |
| DM | 2025-10-03 | 2025-10-02 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +39.3K | 1.18M | +3% | $0 |
| DM | 2025-10-03 | 2025-10-02 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $46.21 | -15.3K | 1.17M | -1% | -$708.2K |
| D | 2025-10-03 | 2025-10-02 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +2,267 | 1.16M | +0.2% | +$57.4K |
| D | 2025-10-03 | 2025-10-02 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $48.06 | -1,904 | 1.16M | -0.2% | -$91.5K |
| D | 2025-10-02 | 2025-10-01 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +53.8K | 1.20M | +5% | +$1.36M |
| D | 2025-10-02 | 2025-10-01 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $48.07 | -40.2K | 1.16M | -3% | -$1.93M |
| D | 2025-10-01 | 2025-09-30 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +11.5K | 1.16M | +1% | +$291.2K |
| D | 2025-10-01 | 2025-09-30 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $48.25 | -8,588 | 1.15M | -0.7% | -$414.4K |
| D | 2025-09-30 | 2025-09-29 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +13.7K | 1.15M | +1% | +$346.3K |
| D | 2025-09-30 | 2025-09-29 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $48.02 | -10.2K | 1.14M | -0.9% | -$491.5K |
| D | 2025-09-24 | 2025-09-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $47.23 | -29.5K | 1.14M | -3% | -$1.39M |
| D | 2025-09-24 | 2025-09-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $12.98 | +47.9K | 1.17M | +4% | +$622.3K |
| D | 2025-09-23 | 2025-09-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $12.98 | +27.1K | 1.14M | +2% | +$351.2K |
| D | 2025-09-23 | 2025-09-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $47.02 | -16.6K | 1.12M | -1% | -$779.9K |
| D | 2025-09-09 | 2025-09-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $46.29 | -6,322 | 1.11M | -0.6% | -$292.6K |
| D | 2025-09-09 | 2025-09-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +8,074 | 1.12M | +0.7% | +$204.3K |
| D | 2025-09-08 | 2025-09-05 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $25.30 | +73.2K | 1.17M | +7% | +$1.85M |
| D | 2025-09-08 | 2025-09-05 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $46.01 | -55.6K | 1.11M | -5% | -$2.56M |
| DM | 2025-08-29 | 2025-08-27+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $12.98 | +56.0K | 1.09M | +5% | +$726.5K |
| DM | 2025-08-29 | 2025-08-27+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $45.10 | -34.8K | 1.09M | -3% | -$1.57M |
| D | 2025-08-27 | 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $45.00 | -1,000 | 1.07M | -0.1% | -$45.0K |
| D | 2025-08-27 | 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $12.98 | +1,611 | 1.07M | +0.2% | +$20.9K |
| D | 2025-08-26 | 2025-08-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $12.98 | +2,415 | 1.07M | +0.2% | +$31.3K |
| D | 2025-08-26 | 2025-08-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $45.00 | -1,500 | 1.07M | -0.1% | -$67.5K |
| DM | 2025-08-08 | 2025-08-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $17.95 | +201.2K | 1.13M | +22% | +$3.61M |
| DM | 2025-08-08 | 2025-08-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $42.02 | -140.0K | 1.03M | -12% | -$5.88M |
| 2025-06-23 | 2025-06-18 | CGTX | COGNITION THERAPEUTICS INC | Khattar Jack A. | Dir | A - Grant | $0.00 | +34.0K | 48.5K | +234% | $0 | |
| 2025-04-03 | 2025-04-02 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +16.9K | 1.01M | +2% | — | |
| I | 2025-04-03 | 2025-04-02 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -16.9K | 1.01M | -2% | — |
| D | 2025-03-11 | 2025-03-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +35.0K | 1.01M | +4% | $0 |
| D | 2025-03-11 | 2025-03-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $32.06 | -16.8K | 991.8K | -2% | -$538.8K |
| D | 2025-03-07 | 2025-03-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +38.6K | 992.2K | +4% | $0 |
| D | 2025-03-07 | 2025-03-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $39.11 | -18.6K | 973.6K | -2% | -$726.7K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $35.59 | -25.2K | 946.2K | -3% | -$898.0K |
| DM | 2024-12-30 | 2024-12-27 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +52.6K | 960.2K | +6% | $0 |
| D | 2024-11-12 | 2024-11-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $36.29 | -125.0K | 926.2K | -12% | -$4.54M |
| D | 2024-11-12 | 2024-11-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.13 | +125.0K | 1.05M | +13% | +$1.14M |
| D | 2024-11-08 | 2024-11-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $36.68 | -125.0K | 926.2K | -12% | -$4.58M |
| D | 2024-11-08 | 2024-11-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.13 | +125.0K | 1.05M | +13% | +$1.14M |
| D | 2024-09-03 | 2024-09-03 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +21.0K | 936.2K | +2% | $0 |
| D | 2024-09-03 | 2024-09-03 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $34.90 | -10.0K | 926.2K | -1% | -$350.6K |
| D | 2024-06-11 | 2024-06-07 | CGTX | COGNITION THERAPEUTICS INC | Khattar Jack A. | Dir | A - Grant | $0.00 | +8,500 | 14.5K | +142% | $0 |
| D | 2024-02-29 | 2024-02-28 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +35.0K | 932.0K | +4% | $0 |
| D | 2024-02-29 | 2024-02-28 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $27.94 | -16.8K | 915.2K | -2% | -$469.1K |
| 2024-02-22 | 2024-02-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +16.5K | 897.0K | +2% | — | |
| I | 2024-02-22 | 2024-02-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -16.5K | 1.02M | -2% | — |
| D | 2023-12-26 | 2023-12-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $27.66 | -12.0K | 880.5K | -1% | -$330.8K |
| D | 2023-12-26 | 2023-12-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +25.0K | 892.5K | +3% | $0 |
| D | 2023-09-07 | 2023-09-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $32.10 | -16.8K | 867.5K | -2% | -$539.4K |
| D | 2023-09-07 | 2023-09-07 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +35.0K | 884.3K | +4% | $0 |
| D | 2023-06-13 | 2023-06-09 | CGTX | COGNITION THERAPEUTICS INC | Khattar Jack A. | Dir | A - Grant | $0.00 | +6,000 | 6,000 | New | $0 |
| D | 2023-05-12 | 2023-05-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $36.47 | -15.0K | 849.3K | -2% | -$547.2K |
| D | 2023-05-12 | 2023-05-11 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +31.2K | 864.3K | +4% | $0 |
| D | 2023-04-10 | 2023-03-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +20.0K | 833.0K | +2% | $0 |
| 2023-02-16 | 2023-02-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +8,750 | 813.0K | +1% | — | |
| I | 2023-02-16 | 2023-02-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -8,750 | 1.04M | -0.8% | — |
| DM | 2023-02-06 | 2023-02-02+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +22.8K | 804.5K | +3% | +$218.4K |
| DM | 2023-02-06 | 2023-02-02+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $42.06 | -13.3K | 804.1K | -2% | -$560.7K |
| D | 2023-02-03 | 2023-02-01 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +498 | 795.5K | +0.1% | +$4,761 |
| D | 2023-02-03 | 2023-02-01 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $42.01 | -300 | 795.2K | -0.0% | -$12.6K |
| D | 2023-02-02 | 2023-01-31 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $42.01 | -976 | 795.0K | -0.1% | -$41.0K |
| D | 2023-02-02 | 2023-01-31 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +1,620 | 795.9K | +0.2% | +$15.5K |
| D | 2023-01-20 | 2023-01-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $40.40 | -4,936 | 794.3K | -0.6% | -$199.4K |
| D | 2023-01-20 | 2023-01-18 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +8,080 | 799.3K | +1% | +$77.2K |
| D | 2023-01-19 | 2023-01-17 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +41.9K | 816.6K | +5% | +$400.8K |
| D | 2023-01-19 | 2023-01-17 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $40.03 | -25.4K | 791.2K | -3% | -$1.02M |
| DA | 2023-01-13 | 2022-03-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | A - Grant | $0.00 | +20.0K | 576.5K | +4% | $0 |
| DA | 2023-01-13 | 2022-03-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +40.0K | 556.5K | +8% | $0 |
| DM | 2022-12-22 | 2022-12-20+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $38.11 | -15.4K | 814.7K | -2% | -$585.3K |
| D | 2022-12-22 | 2022-12-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | A - Grant | $0.00 | +15.6K | 807.6K | +2% | $0 |
| DM | 2022-12-22 | 2022-12-20+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +25.0K | 796.0K | +3% | +$239.0K |
| DM | 2022-11-28 | 2022-11-23+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +21.4K | 785.0K | +3% | +$204.7K |
| DM | 2022-11-28 | 2022-11-23+ | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $35.16 | -13.4K | 789.4K | -2% | -$470.9K |
| D | 2022-11-23 | 2022-11-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +959 | 782.0K | +0.1% | +$9,168 |
| D | 2022-11-23 | 2022-11-22 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $35.00 | -600 | 781.4K | -0.1% | -$21.0K |
| D | 2022-11-22 | 2022-11-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +848 | 781.6K | +0.1% | +$8,107 |
| D | 2022-11-22 | 2022-11-21 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $35.01 | -531 | 781.1K | -0.1% | -$18.6K |
| D | 2022-11-17 | 2022-11-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $35.00 | -1,115 | 780.7K | -0.1% | -$39.0K |
| D | 2022-11-17 | 2022-11-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $9.56 | +1,783 | 781.9K | +0.2% | +$17.0K |
| DM | 2022-09-15 | 2022-09-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $6.40 | +4,515 | 781.5K | +0.6% | +$28.9K |
| DM | 2022-08-18 | 2022-08-16 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $6.41 | +30.3K | 790.2K | +4% | +$194.6K |
| D | 2022-08-18 | 2022-08-16 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $34.01 | -14.7K | 775.6K | -2% | -$499.6K |
| D | 2022-08-17 | 2022-08-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $34.03 | -17.3K | 759.9K | -2% | -$588.8K |
| DM | 2022-08-17 | 2022-08-15 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $6.41 | +35.8K | 788.0K | +5% | +$229.3K |
| D | 2022-08-11 | 2022-08-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +44.9K | 769.9K | +6% | $0 |
| D | 2022-08-11 | 2022-08-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $31.22 | -28.4K | 741.4K | -4% | -$887.8K |
| D | 2022-08-10 | 2022-08-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +63.1K | 764.4K | +9% | $0 |
| D | 2022-08-10 | 2022-08-09 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $31.15 | -39.4K | 725.0K | -5% | -$1.23M |
| D | 2022-08-09 | 2022-08-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +192.0K | 819.2K | +31% | $0 |
| DM | 2022-08-09 | 2022-08-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $31.46 | -117.9K | 711.3K | -14% | -$3.71M |
Purchase Sale Sale after option exercise All abbreviations